Authors


Dylan Zuch, PharmD Candidate

Latest:

Metronidazole Twice Daily: A Pharmacokinetic and Clinical Justification

This medication is associated with a number of adverse effects, such as gastrointestinal upset and peripheral neuropathies, that may be mitigated by less frequent dosing.


Miguel Villa

Latest:

To Deliver Cell and Gene Therapies to More Patients, Innovation in Diagnostic Testing is Essential

Individualized treatments like cell and gene therapies are poised to scale rapidly over the next decade.


John Ostrominski, MD

Latest:

Finerenone Shows Promise in Heart Failure and Kidney Disease Management

John Ostrominski, MD shares insights into the safety and efficacy of finerenone, based on data from the FINEARTS-HF trial.


Mikayla Texido, PharmD Candidate

Latest:

Treating Acid Reflux With Over-the-Counter Medications

An overview of acid reflux and gastroesophageal reflux disease, over-the-counter options, long-term effects of proton pump inhibitors, lifestyle recommendations, and when to refer patients.


Marcella Kinaya, PharmD

Latest:

Marcella Kinaya, PharmD, on Flu Season: ‘We’re Here to Protect People and Make Sure They’re Healthy’

A district leader at CVS Health emphasizes that patients should get tested, be up to date with immunizations, and staying home and reach out to health care professionals when experiencing symptoms.



Donald Levick, MD, MBA

Latest:

Improving Medication Guidance Needs to be a Top Priority for Hospitals, Health Systems

More drugs plus a growing population of older and sicker patients is creating medication-alert overload for already stressed clinicians.


Manish Agrawal, MD

Latest:

Integrating Emotional Healing Through Psychedelics Into Everyday Oncology Practice

Manish Agrawal, MD, discusses the implementation of psilocybin-assisted therapy in a community cancer setting, highlighting its potential to provide sustained relief from depression and anxiety and its significant efficacy advantage over selective serotonin reuptake inhibitors for patients with cancer.



Allyson Gill, PharmD Candidate

Latest:

Case Study: Pharmacist Management of Inappropriate Prednisone Dosing Triggered By Asthma

Holistic and compassionate counseling by a pharmacist and pharmacy-interns on-duty over weekends could positively impact patient lives, especially for older adults and economically disadvantaged patients.


Elise Carpenter, PharmD, BCACP

Latest:

Ambulatory Care Pharmacist-Administered Depression Screenings Can Close Gaps in Care

The study implemented a novel workflow for ambulatory care pharmacists to execute pharmacist-administered depression screenings.


Kevin Chen, PharmD

Latest:

Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using RWD

This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.


Amin Khudari, PharmD Candidate

Latest:

USC ALL Induction Regimen Combined With Newer TKIs Is Safe, Effective for Patients With Ph+ Disease

Achieving MRD flow cytometry negativity is crucial in monitoring and predicting survival outcomes.


Martina Nasralla, PharmD Candidate

Latest:

A Pharmacist’s Guide to Lung Cancer and Its Key Treatments

Though new treatments offer hope, careful monitoring and understanding of risks remain essential for their success.


Steve Martinson

Latest:

The Tao of Tau: Developing the “My Vancomycin Calculator” App

Creating a free app to assist in vancomycin dosing proved to be an entertaining and enlightening journey.



Nick Crozier, PharmD, MBA, BCPS, BCOP

Latest:

Driving Clinical Pharmacy Development With Data-Driven Metrics and Insights

There are no clearly defined, widely accepted clinical pharmacist metrics.


Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA

Latest:

Looking Ahead: Research Priorities and Final Insights

Panelists discuss how advancing chronic graft-vs-host disease (cGVHD) management involves improving steroid response rates, exploring combination therapies, utilizing biomarkers for personalized treatment, and striving for steroid-free first-line options to enhance patient outcomes and reduce long-term adverse effects.


Christy Cheung, PharmD

Latest:

Artificial Intelligence Applications in Education and Pharmacy Practice

By interpreting and applying the data provided by algorithms, pharmacists are uniquely equipped to guide development of more patient-centered care.


Celeste Chung, PharmD

Latest:

An Overview of Vitamins and Supplements in Multiple Sclerosis

By examining the evidence, pharmacists can gain insights into whether these supplements could be integrated into MS treatment regimens to improve patient outcomes.


Steven Pipe, MD

Latest:

Expert: Pharmacists Play Key Role in Counseling, Managing Expectations for Etranacogene Dezaparvovec

Pharmacists are integral to setting patient expectations, monitoring liver health, and ensuring adherence to long-term follow-up for optimal outcomes with etranacogene dezaparvovec.


Amit Patel, MD

Latest:

Pharmacy-Led Enhanced Patient Education in the Emergency Department

In this retrospective study, investigators evaluated a pharmacy-led initiative in the emergency department (ED), finding a potential reduction in ED revisits and hospital readmissions, though results were not statistically significant.


Rachel Chandra, PharmD, MPH, FASHP

Latest:

Understanding Gender-Affirmative Care Beyond Women’s Health

Gender-affirming care and inclusive practices are essential for health equity.


Hannah Ayers

Latest:

Case Studies: May 2022

How would you handle these patients' questions?


Gary Hopkins

Latest:

Medically Integrated Health System Specialty Pharmacies Deliver Strong Outcomes

These facilities provide significant value to payers and patients.


Jerry Rebo, PharmD, BCPS, BCCCP, DPLA

Latest:

Sugammadex: Use Criteria Optimization and Outcomes Data Evaluation

Establishing new use criteria led to an 86% reduction in the utilization of sugammadex with no appreciable impact on measured outcomes.


Enriqueta Felip, MD, PhD

Latest:

Subcutaneous Pembrolizumab Matches IV in Lung Cancer Trial

Enriqueta Felip, MD, PhD, discussed the benefits of subcutaneous pembrolizumab for patients with metastatic non–small cell lung cancer.



Zachery Halford, PharmD, BCOP, BCPPS

Latest:

Immune Checkpoint Inhibitor-Associated Nephritis: A Case of Nivolumab-Induced Acute Kidney Injury in a Patient with Urothelial Carcinoma

This case highlights the importance of recognizing ICPI-AKI, implementing effective therapeutic interventions, and understanding the clinical context to prevent irreversible renal damage.


Shashank R. Cingam, MD

Latest:

Current Treatment Approaches for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Relapsed treatment has evolved with CAR T, bispecific antibodies, and immunotherapies.